1-5 of 5
chile
Close
Save search
Sort by
Journal Articles

Cure at what (systemic) financial cost? Integrating novel therapies into first-line Hodgkin lymphoma treatment

Free
Scott F. Huntington
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 252–259.
https://doi.org/10.1182/hematology.2019000030
Published: 2019
Journal Articles

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

Free
W. Robert Liu, Margaret A. Shipp
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 310–316.
https://doi.org/10.1182/asheducation-2017.1.310
Published: 2017
Journal Articles

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Free
Michelle Fanale
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 406–413.
https://doi.org/10.1182/asheducation-2013.1.406
Published: 2013
Journal Articles

The Present: Optimizing Therapy—Too Much or Too Little?

Free
Nancy L. Bartlett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 108–114.
https://doi.org/10.1182/asheducation-2010.1.108
Published: 2010
Journal Articles

Biology, Clinical Course and Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Free
Lucia Nogová, Thomas Rudiger, Andreas Engert
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 266–272.
https://doi.org/10.1182/asheducation-2006.1.266
Published: 2006